Risankizumab for refractory Crohn’s disease

Dr Aditi Kumar, Deputy Editor of Frontline Gastroenterology and Consultant Gastroenterologist in Wolverhampton, UK interviews Dr Benjamin Zare, Gastroenterology registrar and a clinical research fellow undertaking his PhD at St Marks Academic Institute, London UK and Dr Mark Samaan who is a Consultant Gastroenterologist with a sub-specialist interest in IBD working at Guys and St Thomas NHS Foundation Trust in London, UK, on the paper ' Effectiveness of risankizumab induction and maintenance therapy for refractory Crohn’s disease: a real-world experience from a preapproval access programme and early access to medicines scheme ' published online in Frontline Gastroenterology in October 2024. Listen to our regular podcasts and

You can listen to Risankizumab for refractory Crohn’s disease online on Radio and Podcast. Open the player on this page to stream the available audio.

Risankizumab for refractory Crohn’s disease is an episode from FG podcast by BMJ Group.

This episode is 21:26 long.

This episode was published on Nov 22, 2024.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from FG podcast when more episodes are available from the podcast feed.